AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tubitere 20mg Injection

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Docetaxel (20mg)

Overview Tubitere 20mg Injection

Oncaspar 20mg Injection is a chemotherapy agent indicated for the treatment of breast, non-small cell lung, prostate, and head and neck cancers. Administration is strictly by injection from a qualified healthcare provider. Dosage and frequency are determined individually by your physician, varying based on your specific condition and potentially adjusted over time. Adhere precisely to your doctor's prescribed regimen; incorrect usage or overdose can result in severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinuation is only permissible with your doctor's approval. Common side effects include shortness of breath, constipation, swelling, infections, appetite loss, myalgia, nail abnormalities, pain, and fatigue. Supportive medications may be prescribed to mitigate these effects. Report any unusual bruising or bleeding, sore throat, mouth sores, or fever immediately. This medication can lower blood cell counts (red and white blood cells), increasing infection risk. Regular blood tests to monitor blood cell levels and liver function are mandatory. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, and any concurrent medications, especially those used to combat infections. Significant drug interactions are possible; inform your doctor of all medications you are currently taking. This medication is contraindicated during pregnancy and breastfeeding. Consistent use of effective contraception by both partners is crucial to prevent pregnancy throughout the treatment period.

Uses of Tubitere 20mg Injection

Cancers of the breast, lung (non-small cell), prostate, and head and neck.

Major Benefits of Tubitere 20mg Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

Common Side effects of Tubitere 20mg Injection:

  • Breathlessness
  • Constipation
  • Edema (swelling)
  • Infection
  • Loss of appetite
  • Muscle pain
  • Nail disorder
  • Pain
  • Weakness

How to use Tubitere 20mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Tubitere 20mg Injection works:

Oncaspar 20mg Injection is a chemotherapy agent. Its mechanism of action involves disrupting microtubule networks, essential for cancer cell division and proliferation. This inhibits cancer cell growth, leading to their eventual demise.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Tubitere 20mg Injection and alcohol is not advisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Tubitere 20mg Injection during pregnancy carries established risks to fetal development, making its use inadvisable. Exceptions may exist in critical circumstances where a physician deems the potential benefits outweigh the hazards. Always seek medical counsel.

Breast feedingBreast feedingUNSAFE

Administering Tubitere 20mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant harm from the medication.

DrivingDrivingCONSULT YOUR DOCTOR

Tubitere 20mg Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

In patients with kidney impairment, Tubitere 20mg Injection presents a safe treatment option, requiring no dosage modification.

LiverLiverCAUTION

For individuals with hepatic impairment, administration of Tubitere 20mg Injection requires careful consideration. Dosage modification of Tubitere 20mg Injection might be necessary. Physician consultation is advised.

What if you forget to take Tubitere 20mg Injection :

NA

Facts to Know About Tubitere 20mg Injection

LabelValue
Type of Compound Taxane-based medications
Potential for Dependence None.
Medication Classification Cancer-fighting drugs
Mechanism of Action Microtubule-targeting drugs: Taxane class

FAQs on Tubitere 20mg Injection

Weight gain is a potential side effect of Tubitere 20mg Injection. This can result from fluid retention, often manifesting as initial foot swelling that may subsequently affect the entire body. Contact your physician promptly if you experience foot swelling.
Maintain Tubitere 20mg Injection administration according to your physician's instructions. Treatment length depends on your specific cancer and individual response. Infusion frequency is typically every three weeks.
Tubitere 20mg Injection includes alcohol as an ingredient. Consequently, you might experience drowsiness, disorientation, unsteady gait, or sensations similar to alcohol intoxication. This could compromise your ability to operate vehicles or machinery immediately following administration. Therefore, refrain from alcohol consumption while undergoing treatment with Tubitere 20mg Injection to prevent negative interactions.
The injectable medication Tubitere 20mg is frequently administered in the treatment of breast cancer, specific lung cancers, prostate cancer, stomach cancer, and cancers of the head and neck. Its mechanism of action involves inhibiting cellular growth and proliferation.
Tubitere 20mg Injection is administered intravenously as a liquid solution by healthcare professionals in a clinical setting. The typical dosage regimen is a single injection over a 60-minute period, repeated every three weeks.
Regular blood work, including a complete blood count and liver function panel, will be required before each administration of Tubitere 20mg Injection, as directed by your physician. These tests monitor your blood cell levels and liver health to ensure suitability for treatment. A low white blood cell count can lead to fever or infections.
Alopecia is a known adverse reaction associated with Tubitere 20mg Injection. Hair regrowth typically occurs following cessation of Tubitere 20mg Injection. Nevertheless, irreversible hair loss can sometimes result. Seek medical advice if you experience hair loss related to this medication.
Administration of Tubitere 20mg Injection may result in edema (swelling in the extremities) and serious allergic responses. Prophylactic corticosteroids (dexamethasone) are provided to all patients for three days, commencing one day before Tubitere 20mg Injection is given, to mitigate these risks. For individuals with metastatic castration-resistant prostate cancer, dexamethasone is administered orally at 12, 3, and 1 hour before Tubitere 20mg Injection infusion.
The taxoid anti-cancer agent, Tubitere 20mg Injection, inhibits the proliferation and metastasis of malignant cells.
Tubitere 20mg Injection
2,143
MRP 2,486
13% off